Rational Development of LEA29Y (belatacept), a High‐Affinity Variant of CTLA4‐Ig with Potent Immunosuppressive Properties-Reference-Cited by-同舟云学术

Rational Development of LEA29Y (belatacept), a High‐Affinity Variant of CTLA4‐Ig with Potent Immunosuppressive Properties

Published:2005-02-11 Issue:3 Volume:5 Page:443-453
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:American Journal of Transplantation

Author:

Larsen Christian P.¹²,Pearson Thomas C.¹²,Adams Andrew B.¹,Tso Paul¹,Shirasugi Nozomu¹,StrobertM Elizabeth²,Anderson Dan²,Cowan Shannon¹,Price Karen³,Naemura Joseph⁴,Emswiler John⁴,Greene JoAnne⁴,Turk Lori Ann³,Bajorath Jurgen⁴,Townsend Robert³,Hagerty David³,Linsley Peter S.⁴,Peach Robert J.⁴³

Affiliation:

1. Emory Transplant Center, Department of Surgery, School of Medicine, Emory University Atlanta, Georgia, USA

2. Yerkes National Primate Research Center, School of Medicine, Emory University, Atlanta Georgia, USA

3. Bristol Myers‐Squibb Pharmaceutical Research Institute, Princeton, New Jersey, USA

4. Department of Immunomodulation, Bristol‐Myers Squibb Pharmaceutical Research Institute, Seattle, Washington, USA

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1600-6143.2005.00749.x

Reference27 articles.

1. CD28-B7 interactions in T-cell activation

2. The B7–CD28/CTLA-4 costimulatory pathways in autoimmune disease of the central nervous system

3. CTLA-4 can function as a negative regulator of T cell activation

4. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.

5. Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4

Cited by 657 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Belatacept Versus Tacrolimus for Kidney Transplant Recipients of Deceased Donors With Acute Kidney Injury: US National Database Study;Transplantation;2024-09-04

2. Exhaustion of T cells after renal transplantation;Frontiers in Immunology;2024-08-06

3. PEPTIDE DELIVERY VIA NASAL ROUTE: EXPLORING RECENT DEVELOPMENTS AND APPROACHES;International Journal of Applied Pharmaceutics;2024-07-07

4. Iscalimab Combined With Transient Tesidolumab Prolongs Survival in Pig‐to‐Rhesus Monkey Renal Xenografts;Xenotransplantation;2024-07

5. IL-6 inhibition prevents costimulation blockade-resistant allograft rejection in T cell-depleted recipients by promoting intragraft immune regulation in mice;Nature Communications;2024-06-03